607 related articles for article (PubMed ID: 18087663)
1. Transforming growth factor-beta1-antisense modulates the expression of hepatocyte growth factor/scatter factor in keloid fibroblast cell culture.
Naim R; Naumann A; Barnes J; Sauter A; Hormann K; Merkel D; Aust W; Braun T; Bloching M
Aesthetic Plast Surg; 2008 Mar; 32(2):346-52. PubMed ID: 18087663
[TBL] [Abstract][Full Text] [Related]
2. Targeting TGF-beta1 increases hepatocyte growth factor (HGF/SF) levels in external auditory canal cholesteatoma (EACC) epithelial cell culture.
Naim R; Chang RC; Alfano SS; Riedel F; Bayerl C; Sadick H; Bran G; Hormann K
Regul Pept; 2005 Aug; 130(1-2):75-80. PubMed ID: 15913806
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
4. Effect of transforming growth factor-beta1 antisense oligonucleotides on matrix metalloproteinases and their inhibitors in keloid fibroblasts.
Bran GM; Goessler UR; Baftiri A; Hormann K; Riedel F; Sadick H
Otolaryngol Head Neck Surg; 2010 Jul; 143(1):66-71. PubMed ID: 20620621
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth Factor/Scatter factor (HGF/SF) is a regulator of fibronectin splicing in MDCK cells: comparison between the effects of HGF/SF and TGF-beta1 on fibronectin splicing at the EDA region.
Inoue T; Nabeshima K; Shimao Y; Koono M
Biochem Biophys Res Commun; 1999 Jun; 260(1):225-31. PubMed ID: 10381371
[TBL] [Abstract][Full Text] [Related]
6. TGF-ß1 antisense impacts the SMAD signalling system in fibroblasts from keloid scars.
Bran GM; Sommer UJ; Goessler UR; Hörmann K; Riedel F; Sadick H
Anticancer Res; 2010 Sep; 30(9):3459-63. PubMed ID: 20944123
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of regulation of HGF/SF gene expression in fibroblasts by TGF-beta1.
Harrison P; Bradley L; Bomford A
Biochem Biophys Res Commun; 2000 Apr; 271(1):203-11. PubMed ID: 10777703
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts.
Mou S; Wang Q; Shi B; Gu L; Ni Z
Kaohsiung J Med Sci; 2009 Nov; 25(11):577-87. PubMed ID: 19858036
[TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids.
Lee TY; Chin GS; Kim WJ; Chau D; Gittes GK; Longaker MT
Ann Plast Surg; 1999 Aug; 43(2):179-84. PubMed ID: 10454326
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
[TBL] [Abstract][Full Text] [Related]
11. Differential gene expression in response to transforming growth factor-beta1 by fetal and postnatal dermal fibroblasts.
Rolfe KJ; Irvine LM; Grobbelaar AO; Linge C
Wound Repair Regen; 2007; 15(6):897-906. PubMed ID: 18028139
[TBL] [Abstract][Full Text] [Related]
12. Gene expression of transforming growth factor-beta1 and hepatocyte growth factor during wound healing of injured rat vocal fold.
Ohno T; Hirano S; Rousseau B
Laryngoscope; 2009 Apr; 119(4):806-10. PubMed ID: 19213039
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of melanoma-associated growth factors in keratinocytes and fibroblasts by ultraviolet A and ultraviolet B radiation.
Brenner M; Degitz K; Besch R; Berking C
Br J Dermatol; 2005 Oct; 153(4):733-9. PubMed ID: 16181453
[TBL] [Abstract][Full Text] [Related]
14. The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation.
Lu L; Saulis AS; Liu WR; Roy NK; Chao JD; Ledbetter S; Mustoe TA
J Am Coll Surg; 2005 Sep; 201(3):391-7. PubMed ID: 16125072
[TBL] [Abstract][Full Text] [Related]
15. Expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts in response to transforming growth factor beta1.
Xie JL; Qi SH; Pan S; Xu YB; Li TZ; Liu XS; Liu P
Dermatol Surg; 2008 Sep; 34(9):1216-24; discussion 1224-5. PubMed ID: 18616749
[TBL] [Abstract][Full Text] [Related]
16. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW
Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582
[TBL] [Abstract][Full Text] [Related]
17. Effect of heparin on production of transforming growth factor (TGF)-beta1 and TGF-beta1 mRNA expression by human normal skin and hyperplastic scar fibroblasts.
Fan SQ; Cai JL; Qin LY; Wang ZH; Liu ZZ; Sun ML
Ann Plast Surg; 2008 Mar; 60(3):299-305. PubMed ID: 18443513
[TBL] [Abstract][Full Text] [Related]
18. Basic fibroblast growth factor stimulates hepatocyte growth factor/scatter factor secretion by human mesenchymal cells.
Roletto F; Galvani AP; Cristiani C; Valsasina B; Landonio A; Bertolero F
J Cell Physiol; 1996 Jan; 166(1):105-11. PubMed ID: 8557758
[TBL] [Abstract][Full Text] [Related]
19. [The expression of periostin in hyperplasic scars and the relations to TGF-beta1 and its receptors].
Wang Q; Nie FF; Zhao X; Qin ZL
Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 May; 23(3):229-32. PubMed ID: 17649947
[TBL] [Abstract][Full Text] [Related]
20. Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells.
Xia W; Phan TT; Lim IJ; Longaker MT; Yang GP
Wound Repair Regen; 2004; 12(5):546-56. PubMed ID: 15453837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
